| 1.86 0.08 (4.49%) | 03-04 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 2.36 | 1-year : | 2.56 |
| Resists | First : | 2.02 | Second : | 2.2 |
| Pivot price | 1.85  |
|||
| Supports | First : | 1.75 | Second : | 1.45 |
| MAs | MA(5) : | 1.81 |
MA(20) : | 1.86 |
| MA(100) : | 2.52 |
MA(250) : | 2.63 |
|
| MACD | MACD : | -0.1 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 27.5 |
D(3) : | 23.3 |
| RSI | RSI(14): 46.4 |
|||
| 52-week | High : | 6.42 | Low : | 1.5 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CELZ ] has closed below upper band by 45.0%. Bollinger Bands are 80.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 22 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 1.91 - 1.93 | 1.93 - 1.94 |
| Low: | 1.76 - 1.78 | 1.78 - 1.79 |
| Close: | 1.84 - 1.86 | 1.86 - 1.88 |
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
Tue, 10 Feb 2026
Two Creative Medical cell therapies gain WHO naming milestones - Stock Titan
Tue, 10 Feb 2026
Creative Medical Technology Holdings, Inc. Achieves Milestone with WHO for Second INN Recognition of CELZ-101 - Quiver Quantitative
Tue, 13 Jan 2026
79% of chronic back pain patients had reduced pain in cell therapy test - Stock Titan
Wed, 31 Dec 2025
Creative Medical Technology stockholders approve warrant exercise proposal - Investing.com
Tue, 02 Dec 2025
Creative Medical (NASDAQ: CELZ) gets WHO INN 'olastrocel' for CELZ-201 cell therapy - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Biotechnology
|
|
| Shares Out | 0 (M) |
| Shares Float | 3 (M) |
| Held by Insiders | 2.38e+006 (%) |
| Held by Institutions | 1 (%) |
| Shares Short | 76 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | -5.97e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | -101 % |
| Return on Assets (ttm) | 379.4 % |
| Return on Equity (ttm) | -59.7 % |
| Qtrly Rev. Growth | 6000 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | -47.42 |
| EBITDA (p.s.) | 1739.13 |
| Qtrly Earnings Growth | -2.9 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | -6 (M) |
| PE Ratio | -0.01 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | -0.04 |
| Price to Cash Flow | 1.77 |
| Dividend | 0 |
| Forward Dividend | 332430 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|